Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,434.50 GBX | -0.03% |
|
-5.29% | +6.31% |
04:17am | GSK: seeks expanded indication for RSV vaccine in Japan | CF |
03:28am | Japan accepts GSK application for expanded use of RSV vaccine Arexvy | AN |
Main competitors
Consensus (Composite) | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
GBX 16.66 | +16.12% | 19 | |||||||
$951.98 | +21.27% | 27 | |||||||
$169.18 | +12.24% | 23 | |||||||
DKK 662.18 | +35.58% | 22 | |||||||
$208.86 | +12.6% | 27 | |||||||
CHF 302.63 | +16.4% | 20 | |||||||
- | CHF 118.73 | +2.15% | 19 | ||||||
GBX 179.12 | +26.45% | 20 | |||||||
$101.79 | +28.37% | 24 | |||||||
$314.7 | +8.65% | 28 | |||||||
$29.24 | +22.44% | 23 | |||||||
$116.77 | +8.12% | 26 | |||||||
€114.73 | +38.03% | 23 | |||||||
$499.87 | +11.48% | 28 | |||||||
$57.1 | +21.9% | 22 | |||||||
¥8,303.57 | +15.18% | 14 | |||||||
CN¥64.5 | +25.05% | 16 | |||||||
¥4,946.56 | +15.09% | 16 | |||||||
GBX 4.246 | +11.02% | 17 | |||||||
Average | 903.28 | +18.32% | 22 | ||||||
Weighted average by Cap. | 608.06 | +18.94% | 23 |
- Stock Market
- Equities
- GSK Stock
- Sector GSK plc
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions